---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-040453"
form_type: "8-K"
ticker: "LUDG"
cik: "0001960262"
company_name: "LUDWIG ENTERPRISES, INC."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T09:22:05.522981+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# Ludwig previews Revealia Breast™ cheek-swab test; Q3 2025 launch expected

## Summary
- Revealia Breast™ uses mRNA biomarkers and AI from a cheek swab for early cancer detection.
- Test is in advanced development with expected release in Q3 2025.
- Cites ASBS study: 39.7% non-invasive disease vs 13.2% with traditional management.
- First in pipeline of non-invasive mRNA-based cancer screening tests targeting major cancers.
- No financial data or revenue projections provided in the release.

## SEC filing metadata
- accession: 0001213900-25-040453
- form_type: 8-K
- ticker: LUDG
- cik: 0001960262
- company_name: LUDWIG ENTERPRISES, INC.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/0001213900-25-040453-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/ea0240968-8k_ludwig.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-040453
- JSON: https://secwatch.observer/filing/0001213900-25-040453.json
- Plain text: https://secwatch.observer/filing/0001213900-25-040453.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.